Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Respiratory Medicine and

Journal Scan / Research · March 13, 2020

First Known Person-to-Person Transmission of COVID-19 in the United States

The Lancet

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Shyoko Honiden MD, MSc

The Lancet

First Known Person-to-Person Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the USA

Lancet 2020 Mar 12;[EPub Ahead of Print], I Ghinai, TD McPherson, JC Hunter, HL Kirking, D Christiansen, K Joshi, R Rubin, S Morales-Estrada, SR Black, M Pacilli, MJ Fricchione, RK Chugh, KA Walblay, NS Ahmed, WC Stoecker, NF Hasan, DP Burdsall, HE Reese, M Wallace, C Wang, D Moeller, J Korpics, SA Novosad, I Benowitz, MW Jacobs, VS Dasari, MT Patel, J Kauerauf, EM Charles, NO Ezike, V Chu, CM Midgley, MA Rolfes, SI Gerber, X Lu, S Lindstrom, JR Verani, JE Layden

COVID-19

First Known Person-to-Person Transmission of COVID-19 in the United States

Additional Info

First Known Person-to-Person Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the USA

Further Reading

Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes

Radiologic Identification of Patients With Asymptomatic Mycobacterium avium Complex Pulmonary Infections

Novel Definitions of Wellness and Distress Among Family Caregivers of Patients With Acute Cardiorespiratory Failure

Vaccine Effectiveness Against Long COVID in Children and Adolescents

Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement

Effect of Inhaled Treprostinil on Long-Term Survival in Patients With Pulmonary Hypertension Associated With ILD

Early Postnatal High-Dose Fat-Soluble Enteral Vitamin A Supplementation to Lower Risk for Moderate or Severe Bronchopulmonary Dysplasia or Death in Infants With Extremely Low Birthweight

Risk-Based Lung Cancer Screening Performance in a Universal Healthcare Setting

Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in the US Hospitals

Serum Cytokine Biosignatures for Identification of Tuberculosis Among HIV-Positive Inpatients

Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation

Recently Updated